Scotiabank Poll: Trusted Advice Tops List of Needs for First-Time Homebuyers

Poll reveals growing demand for guidance amid affordability concerns and market uncertainty First-time homebuyers are seeking trusted advice as they navigate affordability challenges and uncertainty, according to the latest Scotiabank Housing Poll, which focused on the experience and attitudes of Canadians surrounding homeownership. With 95% of first-time buyers saying reliable advice would make them feel […]

Galaxy Expands into Liquid Staking as Development Company for Liquid Collective

Acquisition of Alluvial Finance, former Development Company behind Liquid Collective, adds engineering talent and expands Galaxy's institutional staking infrastructure Galaxy Digital Inc. (NASDAQ: GLXY) (TSX: GLXY) (the “Company” or “Galaxy”), a global leader in digital assets and data center infrastructure, today announced that it is now the Development Company for Liquid Collective, the leading enterprise-grade

USA Rare Earth Subsidiary LCM Partners with Arnold Magnetic Technologies to Secure Rare Earth Metals Supply

(NasdaqGM:USAR),(NasdaqGM:USARW), STILLWATER, Okla., Dec. 04, 2025 (GLOBE NEWSWIRE) — USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company) today announced that its subsidiary, Less Common Metals (LCM), signed a supply agreement with Solvay and Arnold Magnetic Technologies Corporation (Arnold), a subsidiary of Compass Diversified (NYSE: CODI). Leveraging LCM's metal and alloy making expertise, the

Way.com Welcomes Automotive SaaS Veteran Arnold Gold to Lead New Way Repair Division

Industry leader will drive Way's expansion into AI-enabled vehicle repair and maintenance solutions Way.com announced today that Arnold Gold has joined the company as Executive Vice President of Way Repair, the company's newest business line focused on modernizing the repair and maintenance experience for drivers and auto shops. In this role, Gold will lead the

TNL Mediagene Launches LINE Utility Tool “iGood Price-Drop Radar” in Taiwan, Building on JPY200 Million Crowdfunding Success in Japan to Accelerate Media × Tech Roadmap

TNL Mediagene will launch “iGood Price-Drop Radar” in mid-December, its first internally developed LINE-based price-drop notification utility tool, designed to deliver automated price-drop alerts for e-commerce The tool integrates with the Company's successful shopping and lifestyle media brand iGood and leverages LINE's ubiquity to integrate price tracking into everyday conversations, reducing user friction and addressing

SciNeuro Pharmaceuticals Announces $53 Million Financing to Further Advance Pipeline of Therapies for Neurodegenerative Diseases and Appointment of Chief Financial Officer

— Financing led by LAV and ARCH Venture Partners with participation from new and existing investors — Appoints Hogan Wan as Chief Financial Officer to lead financial management, strategy and operation SciNeuro Pharmaceuticals (“SciNeuro”), a biotech company pioneering the development of novel treatments for neurodegenerative diseases, today announced the completion of a total of $53

USA Rare Earth Subsidiary LCM Partners with Arnold Magnetic Technologies to Secure Rare Earth Metals Supply

USA Rare Earth Subsidiary LCM Partners with Arnold Magnetic Technologies to Secure Rare Earth Metals Supply GlobeNewswire December 04, 2025 STILLWATER, Okla., Dec. 04, 2025 (GLOBE NEWSWIRE) — USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company) today announced that its subsidiary, Less Common Metals (LCM), signed a supply agreement with Solvay and Arnold

Replicate Bioscience and Instituto Butantan Enter Collaborative Agreement to Develop and Commercialize Replicate’s Self-Replicating RNA (srRNA) Rabies Vaccine in Latin America

Under the agreement, Instituto Butantan will conduct registrational clinical trials of Replicate's novel srRNA rabies vaccine for post-exposure and pre-exposure prophylaxis Replicate to provide GMP material for clinical trials and transfer manufacturing process to Butantan mRNA vaccine production facility Replicate retains rights for development in markets outside of Latin America Replicate Bioscience, a clinical-stage company

Scroll to Top